QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lixte-biotech-hldgs-q2-eps-029-up-from-045-yoy

Lixte Biotech Hldgs (NASDAQ:LIXT) reported quarterly losses of $(0.29) per share. This is a 35.56 percent increase over losses ...

 lixte-biotechnologys-lb100-highlighted-in-nature-study-showing-pp2a-inhibition-enhances-immunotherapy-response-in-ovarian-and-colorectal-cancers

Article Indicates that Inhibition of PP2A Enhances Immunotherapy Responsewith LIXTE's Proprietary Compound LB100PASADENA, C...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION